To ensure the quality and safety of medical services in primary healthcare institutions, China’s National Health Commission (NHC) and other relevant authorities issued a notice on 1 April 2026, outlining a three-year nationwide action.

Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

A trio of chemists at Indiana University Bloomington has created a new sensor to detect chemical changes in immune cells during the breakdown of pathogens.

Recently, the 2021 International Market Briefing & Financial Analyst Briefing held in conjunction with the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo ended successfully in Atlanta, USA.

The ability to detect a tumor earlier, when it is smaller, reduces the impact of surgery and treatment, improving the prognosis for many patients.

During the pandemic, it has become evident that people with cardiovascular disease and obesity are at much higher risk of developing very severe, even fatal COVID-19 disease. Researchers at Karolinska Institutet have identified some metabolic processes that SARS-CoV-2 uses to attack lung tissue.

A new study has used a state-of-the-art blood test to track damage to the brain in people who have sustained traumatic brain injury (TBI).

Early in the COVID-19 pandemic, individuals with Alzheimer's disease were identified as being at increased risk of developing severe COVID-19.

Chinese startup Sansure Biotech on Sunday won the award for healthcare innovation at the G20 Innovation League, a competition between 100 startups from over 20 countries.

Hologic has launched its Novodiag system in Europe. The Waltham, MA-based company inherited the automated molecular diagnostic solution for on-demand testing of infectious diseases and antimicrobial resistance when it acquired Mobidiag Oy for $795 million.

Quidel announced Thursday that preliminary estimates for its third quarter revenues are expected to rise between 6 and 7 percent year over year on COVID-19 assay sales.

PerkinElmer said on Thursday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's assay to detect SARS-CoV-2 and the flu.